These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30296868)

  • 1. Mesenchymal stromal cells in the treatment of perianal fistulas in Crohn's disease.
    Castro-Poceiro J; Fernández-Clotet A; Panés J
    Immunotherapy; 2018 Oct; 10(14):1203-1217. PubMed ID: 30296868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.
    Panés J; García-Olmo D; Van Assche G; Colombel JF; Reinisch W; Baumgart DC; Dignass A; Nachury M; Ferrante M; Kazemi-Shirazi L; Grimaud JC; de la Portilla F; Goldin E; Richard MP; Leselbaum A; Danese S;
    Lancet; 2016 Sep; 388(10051):1281-90. PubMed ID: 27477896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First clinical case report of local microinjection of autologous fat and adipose-derived stromal vascular fraction for perianal fistula in Crohn's disease.
    Philandrianos C; Serrero M; Grimaud F; Magalon J; Visée C; Velier M; Francois P; Orsoni P; Magalon G; Grimaud JC; Desjeux A; Véran J; Sabatier F
    Stem Cell Res Ther; 2018 Jan; 9(1):4. PubMed ID: 29321063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn's Disease.
    Swaroop S; Vuyyuru SK; Kante B; Kumar P; Mundhra SK; Arora U; Goyal A; Kandasamy D; Sharma R; Kabilan K; Kedia S; Dash NR; Ahuja V
    Stem Cell Res Ther; 2024 May; 15(1):140. PubMed ID: 38745184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local fistula injection of allogeneic human amnion epithelial cells is safe and well tolerated in patients with refractory complex perianal Crohn's disease: a phase I open label study with long-term follow up.
    Keung C; Nguyen TC; Lim R; Gerstenmaier A; Sievert W; Moore GT
    EBioMedicine; 2023 Dec; 98():104879. PubMed ID: 38042747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Darvadstrocel for the treatment of perianal fistulas in Crohn's disease.
    Meng ZW; Baumgart DC
    Expert Rev Gastroenterol Hepatol; 2020 Jun; 14(6):405-410. PubMed ID: 32354239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas.
    Barnhoorn MC; Wasser MNJM; Roelofs H; Maljaars PWJ; Molendijk I; Bonsing BA; Oosten LEM; Dijkstra G; van der Woude CJ; Roelen DL; Zwaginga JJ; Verspaget HW; Fibbe WE; Hommes DW; Peeters KCMJ; van der Meulen-de Jong AE
    J Crohns Colitis; 2020 Jan; 14(1):64-70. PubMed ID: 31197361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's disease.
    Molendijk I; van der Meulen-de Jong AE; Verspaget HW; Veenendaal RA; Hommes DW; Bonsing BA; Peeters KCMJ
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1148-1154. PubMed ID: 30095479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.
    Molendijk I; Bonsing BA; Roelofs H; Peeters KC; Wasser MN; Dijkstra G; van der Woude CJ; Duijvestein M; Veenendaal RA; Zwaginga JJ; Verspaget HW; Fibbe WE; van der Meulen-de Jong AE; Hommes DW
    Gastroenterology; 2015 Oct; 149(4):918-27.e6. PubMed ID: 26116801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Darvadstrocel: A Review in Treatment-Refractory Complex Perianal Fistulas in Crohn's Disease.
    Scott LJ
    BioDrugs; 2018 Dec; 32(6):627-634. PubMed ID: 30298387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series.
    Cabalzar-Wondberg D; Turina M; Biedermann L; Rogler G; Schreiner P
    Colorectal Dis; 2021 Jun; 23(6):1444-1450. PubMed ID: 33595166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.
    Ciccocioppo R; Bernardo ME; Sgarella A; Maccario R; Avanzini MA; Ubezio C; Minelli A; Alvisi C; Vanoli A; Calliada F; Dionigi P; Perotti C; Locatelli F; Corazza GR
    Gut; 2011 Jun; 60(6):788-98. PubMed ID: 21257987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem-cell therapy for perianal fistulas in Crohn's disease: a systematic review and meta-analysis.
    Cheng F; Huang Z; Li Z
    Tech Coloproctol; 2019 Jul; 23(7):613-623. PubMed ID: 31286287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection.
    Laureti S; Gionchetti P; Cappelli A; Vittori L; Contedini F; Rizzello F; Golfieri R; Campieri M; Poggioli G
    Inflamm Bowel Dis; 2020 Jan; 26(2):321-330. PubMed ID: 31220252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoproliferative Disease in the Rectum 4 Years After Local Mesenchymal Stromal Cell Therapy for Refractory Perianal Crohn's Fistulas: A Case Report.
    Barnhoorn MC; Van Halteren AGS; Van Pel M; Molendijk I; Struijk AC; Jansen PM; Verspaget HW; Dijkstra G; Oosten LEM; Van der Meulen-de Jong AE
    J Crohns Colitis; 2019 May; 13(6):807-811. PubMed ID: 30561580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cell therapy for therapy refractory complex Crohn's perianal fistulas: a case series.
    Pronk AJM; Beek KJ; Wildenberg ME; Bemelman WA; Stoker J; Buskens CJ
    Stem Cell Res Ther; 2024 Jun; 15(1):161. PubMed ID: 38853278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells transplantation for perianal fistulas: a systematic review and meta-analysis of clinical trials.
    Wang H; Jiang HY; Zhang YX; Jin HY; Fei BY; Jiang JL
    Stem Cell Res Ther; 2023 Apr; 14(1):103. PubMed ID: 37101285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn's Disease.
    Dige A; Hougaard HT; Agnholt J; Pedersen BG; Tencerova M; Kassem M; Krogh K; Lundby L
    Gastroenterology; 2019 Jun; 156(8):2208-2216.e1. PubMed ID: 30772343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year outcome of local injection of autologous stromal vascular fraction cells and microfat in refractory perianal fistulas of Crohn's disease.
    Guillo L; Grimaud F; Houser F; Prost C; Jouve E; Philandrianos C; Abellan M; Veran J; Visee C; Beyer-Berjot L; Desjeux A; Dignat-George F; Leone M; Grimaud JC; Sabatier F; Serrero M; Magalon J
    Stem Cell Res Ther; 2022 Feb; 13(1):67. PubMed ID: 35139888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Darvadstrocel for Complex Perianal Fistulas in Japanese Adults with Crohn's Disease: A Phase 3 Study.
    Furukawa S; Mizushima T; Nakaya R; Shibata M; Yamaguchi T; Watanabe K; Futami K
    J Crohns Colitis; 2023 Apr; 17(3):369-378. PubMed ID: 36149832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.